Skip to main content
Jia Yin, MD, Ophthalmology, Boston, MA

JiaYinMDPhD

Ophthalmology Boston, MA

Cornea & External Disease, Refractive Surgery

Physician

Dr. Yin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yin's full profile

Already have an account?

  • Office

    243 Charles St
    Boston, MA 02114
    Phone+1 617-523-7900

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 2015 - 2017
  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityResidency, Ophthalmology, 2012 - 2015
  • Detroit Medical Center/Wayne State University (Sinai-Grace)
    Detroit Medical Center/Wayne State University (Sinai-Grace)Internship, Transitional Year, 2011 - 2012
  • Wayne State University
    Wayne State UniversityPh.D., Vision science, 2008
  • Capital University of Medical Sciences
    Capital University of Medical SciencesClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2015 - 2025
  • MI State Medical License
    MI State Medical License 2011 - 2015
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Journal Articles

  • Association of Α-melanocyte–Stimulating Hormone with Corneal Endothelial Cell Survival During Oxidative Stress and Inflammation-Induced Cell Loss in Donor Tissue  
    Ula V Jurkunas, Jia Yin, Reza Dana, JAMA Ophthalmology

Press Mentions

  • HMN 2025: How Novel Stem Cell Remedy Repairs ‘Irreversible’ Corneal Harm in Scientific Trial
    HMN 2025: How Novel Stem Cell Remedy Repairs ‘Irreversible’ Corneal Harm in Scientific TrialMarch 5th, 2025
  • Novel Stem Cell Therapy Repairs Irreversible Corneal Damage in Clinical Trial
    Novel Stem Cell Therapy Repairs Irreversible Corneal Damage in Clinical TrialMarch 4th, 2025
  • Stem Cell Therapy Repairs Blinding Corneal Damage in Trial
    Stem Cell Therapy Repairs Blinding Corneal Damage in TrialMarch 4th, 2025
  • Join now to see all

Grant Support

  • Tissue Hypoxia and Topical Oxygen Therapy in Ocular Mustard Gas InjurySCHEPENS EYE RESEARCH INSTITUTE2023–2025